000 01307 a2200361 4500
005 20250515024751.0
264 0 _c20060925
008 200609s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/j.bmcl.2006.04.049
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSun, Qi
245 0 0 _aNovel class of cyclophosphamide prodrug: cyclophosphamide spiropiperaziniums (CPSP).
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cJul 2006
300 _a3727-30 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xchemical synthesis
650 0 4 _aCyclophosphamide
_xanalogs & derivatives
650 0 4 _aInhibitory Concentration 50
650 0 4 _aMice
650 0 4 _aPiperazines
_xchemical synthesis
650 0 4 _aProdrugs
650 0 4 _aSpiro Compounds
_xchemical synthesis
650 0 4 _aStructure-Activity Relationship
700 1 _aLi, Run-Tao
700 1 _aGuo, Wei
700 1 _aCui, Jing-Rong
700 1 _aCheng, Tie-Ming
700 1 _aGe, Ze-Mei
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 16
_gno. 14
_gp. 3727-30
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2006.04.049
_zAvailable from publisher's website
999 _c16282987
_d16282987